November 21, 2024

Exploring Blood-Based Biomarkers and Treatment Eligibility in Alzheimer Disease: Gil Rabinovici, MD

The professor of neurology and radiology at University of California, San Francisco, discussed the potential of blood-based biomarkers in Alzheimer treatment eligibility, highlighting current limitations and the importance of safety monitoring. [WATCH TIME: 7 minutes]

November 21, 2024

Exploring Blood-Based Biomarkers and Treatment Eligibility in Alzheimer Disease: Gil Rabinovici, MD – Neurology Live

November 21, 2024

In a first, a Pittsburgh-based scientist and researcher joins Alzheimer’s Association board – Pittsburgh Post-Gazette

November 21, 2024

New schizophrenia drug could treat Alzheimer’s disease – Nature.com

November 21, 2024

Study links prenatal immune activity to Alzheimer’s risk in later life – News-Medical.Net